COREY LUM: Open Payments
NPI 1952668220 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,003 in 46 payments from 13 companies in 2025. Trend: 2023 $40,378 · 2024 $23,954 · 2025 $6,003
Speaker / faculty: $2,679Food & beverage: $2,397Travel & lodging: $927
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $2,814 |
| Abbott Laboratories | 21 | $1,833 |
| ABIOMED | 2 | $284 |
| AstraZeneca Pharmaceuticals LP | 2 | $256 |
| Medtronic, Inc. | 9 | $192 |
| BridgeBio Pharma, Inc. | 1 | $149 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| Inspire Medical Systems, Inc. | 1 | $119 |
| Alnylam Pharmaceuticals Inc. | 1 | $112 |
| Philips North America LLC | 2 | $51 |
Products named: CAMZYOS, CARDIOMEMS, AFFERA MAPPING SYSTEM, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Attruby, WINREVAIR, WAINUA, INSPIRE.
Industry payments across NV — which companies pay providers there.
